These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15228186)

  • 41. Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis.
    Ellingsen T; Hansen I; Thorsen J; Kuno Møller B; Tarp U; Jacobsen S; Lund Hetland M; Vestergaard A; Hørslev-Petersen K; Stengaard-Pedersen K
    Clin Exp Rheumatol; 2012; 30(1):58-63. PubMed ID: 22273590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.
    Mäkinen H; Kautiainen H; Hannonen P; Möttönen T; Leirisalo-Repo M; Laasonen L; Korpela M; Blåfield H; Hakola M; Sokka T
    J Rheumatol; 2007 Feb; 34(2):316-21. PubMed ID: 17183623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A.
    Pasero G; Priolo F; Marubini E; Fantini F; Ferraccioli G; Magaro M; Marcolongo R; Oriente P; Pipitone V; Portioli I; Tirri G; Trotta F; Della Casa-Alberighi O
    Arthritis Rheum; 1996 Jun; 39(6):1006-15. PubMed ID: 8651963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Longterm Effect of Early Intensive Treatment of Seniors with Rheumatoid Arthritis: A Comparison of 2 Population-based Cohort Studies on Time to Joint Replacement Surgery.
    Widdifield J; Moura CS; Wang Y; Abrahamowicz M; Paterson JM; Huang A; Beauchamp ME; Boire G; Fortin PR; Bessette L; Bombardier C; Hanly JG; Feldman D; Bernatsky S;
    J Rheumatol; 2016 May; 43(5):861-8. PubMed ID: 26879353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
    Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
    Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment.
    Finckh A; Choi HK; Wolfe F
    Ann Rheum Dis; 2006 Sep; 65(9):1192-7. PubMed ID: 16540549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of rheumatoid arthritis following adjunct statin therapy.
    Das S; Mohanty M; Padhan P
    Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term treatment of destructive rheumatoid arthritis with methotrexate.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1997 Oct; 24(10):1881-9. PubMed ID: 9330927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
    Jonsson MK; Sundlisæter NP; Nordal HH; Hammer HB; Aga AB; Olsen IC; Brokstad KA; van der Heijde D; Kvien TK; Fevang BS; Lillegraven S; Haavardsholm EA
    Ann Rheum Dis; 2017 Dec; 76(12):2031-2037. PubMed ID: 28814431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review.
    Kuijper TM; Lamers-Karnebeek FB; Jacobs JW; Hazes JM; Luime JJ
    J Rheumatol; 2015 Nov; 42(11):2012-22. PubMed ID: 26428204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis.
    Gonzalez-Alvaro I; Carmona L; Balsa A; Sanmarti R; Belmonte MA; Tena X;
    J Rheumatol; 2003 Apr; 30(4):697-704. PubMed ID: 12672186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
    Emery P; Bingham CO; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME
    Ann Rheum Dis; 2017 Jan; 76(1):96-104. PubMed ID: 27165179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis.
    McQueen FM; Benton N; Perry D; Crabbe J; Robinson E; Yeoman S; McLean L; Stewart N
    Arthritis Rheum; 2003 Jul; 48(7):1814-27. PubMed ID: 12847674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort.
    Louveau B; De Rycke Y; Lafourcade A; Saraux A; Guillemin F; Tubach F; Fautrel B; Hajage D
    Rheumatology (Oxford); 2018 Sep; 57(9):1563-1573. PubMed ID: 29796624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis.
    Plant MJ; Williams AL; O'Sullivan MM; Lewis PA; Coles EC; Jessop JD
    Arthritis Rheum; 2000 Jul; 43(7):1473-7. PubMed ID: 10902748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis.
    Alarcón GS; López-Méndez A; Walter J; Boerbooms AM; Russell AS; Furst DE; Rau R; Drosos AA; Bartolucci AA
    J Rheumatol; 1992 Dec; 19(12):1868-73. PubMed ID: 1345138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiographic changes and factors associated with subsequent progression of damage in weight-bearing joints of patients with rheumatoid arthritis under TNF-blocking therapies-three-year observational study.
    Matsushita I; Motomura H; Seki E; Kimura T
    Mod Rheumatol; 2017 Jul; 27(4):570-575. PubMed ID: 27589926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.
    Graudal N; Jürgens G
    Arthritis Rheum; 2010 Oct; 62(10):2852-63. PubMed ID: 20560138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term impact of delay in assessment of patients with early arthritis.
    van der Linden MP; le Cessie S; Raza K; van der Woude D; Knevel R; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2010 Dec; 62(12):3537-46. PubMed ID: 20722031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.